Pharmaceutical products, namely, small molecules, biologics and gene therapies, for the treatment of central nervous system diseases and disorders; biological preparations for use in medical and clinical gene therapy; clinical medical reagents for use in nucleic acid-based therapy, gene therapy, cell therapy, gene diagnostic and gene testing; pharmaceutical preparations for the treatment of central nervous system diseases and disorders, and other pharmaceuticals for the prevention of onset an...